Composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/435 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 9/48 (2006.01) A61K 31/439 (2006.01)

Patent

CA 2323177

Controlled release dosage forms useful in the treatment and/or prophylaxis of dementia, including Alzheimer's disease, in mammals, and for enhancing amyloid precursor protein processing along a non-amyloidogenic pathway in patients suffering from, or at risk of developing, Alzheimer's disease.

L'invention concerne des formes galéniques à libération prolongée, utiles chez les mammifères dans le traitement et/ou la prophylaxie de la démence, notamment de la maladie d'Alzheimer, et destinées à accroître le processus de traitement de la protéine précurseur de l'amyloïde, le long d'un trajet non amyloïdogène, chez des patients souffrant de la maladie d'Alzheimer ou présentant un risque de développement de cette maladie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1416041

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.